Keith M Vogt

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Keith M Vogt sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 4 currently recruiting 3 completed early-phase tilt upper quartile by trial count

Keith M Vogt: 7 sponsored US clinical trials, 4 recruiting.

Keith M Vogt sponsors 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 3 completed. 0 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anesthesia, with 3 trials.

Upper-quartile sponsor footprint

Keith M Vogt sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Keith M Vogt pipeline

4 recruiting of 7 indexed (57% open); 3 completed (43%).

Phase mix: 0 late (III/IV) vs 6 early (I/II) (early-phase heavy).

Top condition: Anesthesia (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Keith M Vogt: open-pipeline peers nationwide

Peers matched on 7 registered trials and 57% open enrollment, not the therapeutic-area sidebar.

Keith M Vogt sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 6.97.07.077.07.07.1 0%20%40%60% Total trials Recruiting share Keith M Vogt3M4Life Research89bioAbbott Diagnostics DivisionAlimentivAura BiosciencesBicycleTx LimitedBinghamton University
Keith M Vogt sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Keith M Vogt sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 57% open enrollment (± trial volume)

What to do with this Keith M Vogt page

7 registered trials is a research-attention snapshot, not an endorsement of Keith M Vogt or any single study.

  • 4 of Keith M Vogt's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Anesthesia is the condition Keith M Vogt studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anesthesia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Keith M Vogt pipeline card: 7 registered trials from official public datasets.Report a data error.